Abstract
Glial growth factor 2 (GGF2) is a neuronal signal that promotes the proliferation and survival of the oligodendrocyte, the myelinating cell of the central nervous system (CNS). This study has focused on recombinant human GGF2 (rhGGF2) and it’s potential to affect clinical recovery and repair to damaged myelin in chronic relapsing experimental autoimmune encephalomyelitis (EAE) in the mouse, a major animal model for the human demyelinating disease, multiple sclerosis (MS). Mice with EAE were treated with rhGGF2 during both the acute and relapsing phases, and GGF2 treatment led to delayed signs, decreased severity and resulted in statistically significant reductions in relapse rate. Further, rhGGF2-treated groups displayed CNS lesions with more remyelination than in controls. This correlated with increased expression of myelin basic protein exon 2, a marker for remyelination, and with an increase of the regulatory cytokine, IL-10. Thus, a beneficial effect of a neurotrophic growth factor has been demonstrated upon the clinical, pathologic and molecular manifestations of autoimmune demyelination, an effect that was associated with increased expression of a Th2 cytokine. rhGGF2 treatment may represent a novel approach to the treatment of MS (Cannella et al., 1998).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brosnan, C.F., Racke, M.K., and Selmaj, K. (1997) in Multiple Sclerosis Clinical and Pathogenetic Basis, eds. Raine, C.S., McFarland, H.F., and Tourtellotte, W.W. (Chapman and Hall, London), pp. 325–
Cannella B., Hoban, C.J., Gao Y., Garcia-Arenas. R., Lawson D., Marchionni M., Gwynne D., and Raine, C.S. (1998). Proc. Nat. Acad. Sci., USA, 95, 10100–10105.
Canoll, P.D., Musacchio, J.M., Hardy R., Reynolds R., Marchionni, M.A., and Salzer, J.L. (1996) Neuron 17, 229–243.
Capello E., Voskuhl, R.R., McFarland, H.F., and Raine, C.S. (1997) Ann. Neurol. 41, 797–805.
Claudio L., Raine, C.S., and Brosnan, C.F. (1995) Acta Neuropathol. 90, 228–238.
Goodkin, D.E. (1997) in Multiple Sclerosis Clinical and Pathogenetic Basis, eds. Raine, C.S., McFarland, H.F., and Tourtellotte, W.W. (Chapman and Hall, London), pp. 307–324.
Gassmann, M. and Lemke, G. (1997) Curr. Opin. Neurobiol. 7, 87–92.
Ijichi A., Noel F., Sakuma S., Weil, M.M., and Tofilon, P.J. (1996) Ex vivo gene delivery of platelet-derived growth factor increases O-2A progenitors in adult rat spinal cord. Gene Therapy. 3, 389–395.
Jordan C., Friedrich V., and Dubois-Dalcq, M. (1989) J. Neurosci. 9, 248–257.
Kamholz J., Toffeneti J., and Lazzarini, R.A. (1988) J. Neurosci. Res. 21, 62–70.
Kennedy, M.K., Torrance, D.S., Picha, K.S., and Mohler, K.M. (1992) J. Immunol 149, 2496–2505.
Kwon, E.E. and Prineas, J.W. (1994) J. Neuropath. Exp. Neurol. 53, 617–624.
Marchionni, M.A., Goodearl, A.D., Chen, M.S., Bermingham, McDonogh O., Kirk C., Hendricks M., Danehy D., Misumi D., Sudhalfer J., and Kobayashi, D. et al. (1993) Nature 362, 312–318.
Marchionni, M.A., Kirk, C.J., Isaacs, I.J., Hoban, C.J., Mahanthappa, N.K., Anton, E.S., Chen C., Wason F., Lawson D., and Hamers, F.T.P. et al. (1996) Cold Spring Harbor Symp. 61, 459–472.
Milner, R. Anderson, H.J., Rippon, R.F., McKay, J.S., Franklin, R.J., Marchionni, M.A., Reynolds R., and Ffrench-Constant, C. (1997) Glia 19, 85–90.
Mokhtarian F., McFarlin, D.E., and Raine, C.S. (1984) Nature 309, 356–358.
Nagasato K., Farris, R.W., Dubois-Dalcq M., and Voskuhl, R.R. (1997) J. Neuroimmunol. 72, 21–25.
Noel F., Happel, Marchionni, M.A., and Tofilon, P.J. (1998). Submitted.
Prineas, J.W. and McDonald, W.I. (1997) in Greenfield’s Neuropathology, eds. Graham, D.I., and Lantos, P.L. (Oxford University Press, Oxford), pp. 813–896.
Raine, C.S. (1984) Lab. Invest. 50, 608–635.
Raine, C.S. (1997) in Multiple Sclerosis Clinical and Pathogenetic Basis,eds. Raine, C.S., McFarland, H.F., and Tourtellotte, W.W. (Chapman and Hall, London), pp. 243–2
Rodriguez, M. (1991) Lab. Invest. 64, 358–370.
Rutkowski, J.L., Kirk, C.J., Lerner, M.A., and Tennekoon, G.I. (1995) Nature Med. 1, 24–25.
Shi J., Marinovich A., and Barres, B.A. (1998) J. Neurosci. 18, 4627–4636.
Trapp, B.D, Peterson J., Ransohoff, R.M., Rudick R., Mork S., and Bo, L. (1998) New Eng. J. Med. 338, 323–325.
van derMaazen R.W.M, Verhagen I, and van der Kogel A.J. Int J Radiat Biol. (1990) 58, 835–844.
Wolswijk, G. (1998) J. Neurosci. 18(2), 601–609.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Marchionni, M.A. et al. (1999). Neuregulin in Neuron/Glial Interactions in the Central Nervous System. In: Matsas, R., Tsacopoulos, M. (eds) The Functional Roles of Glial Cells in Health and Disease. Advances in Experimental Medicine and Biology, vol 468. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4685-6_23
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4685-6_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7121-2
Online ISBN: 978-1-4615-4685-6
eBook Packages: Springer Book Archive